Saw Palmetto and Natural DHT Blockers for Hair Loss: What the Evidence Shows
Once the diagnosis is clear, saw palmetto, if you take it, works best as one part of a plan rather than the plan itself. Supplements and prescription blockers act on the DHT signal; PRP treatment works directly on the follicle, so in clinic we usually run PRP alongside whatever else someone is using rather than asking them to pick one. In our internal case series, 87% of people had visible regrowth at week 16.
Saw palmetto has some early clinical evidence for pattern hair loss, but it is weaker than prescribed treatment. In the largest head-to-head trial, 38% of men taking saw palmetto improved their hair density over 24 months, against 68% taking finasteride. It can be a reasonable option for mild thinning if you understand the limits. It is not a substitute for a diagnosis. [1]
Supplements are an easy first purchase when hair starts to thin. This guide sets out what saw palmetto and other natural DHT blockers have actually been shown to do, what they cannot do, and how they compare with the treatments doctors reach for first.
Message the team on WhatsApp .
What is saw palmetto?
Saw palmetto is an extract from the berries of the Serenoa repens palm. It has antiandrogenic properties, which means it can reduce the effect of the hormones that shrink hair follicles in pattern hair loss. That is why it is sold as a natural DHT blocker. [1,3]
DHT, or dihydrotestosterone, is the hormone that drives androgenetic alopecia, the hereditary pattern loss that affects up to half of all men and women at some point. In men it usually starts at the temples and crown. In women it usually shows as diffuse thinning over the top of the head with the frontal hairline kept. [3]
What did the trials find?
A 2020 systematic review gathered every published clinical study of saw palmetto for hair loss. It found five randomised controlled trials and two prospective cohort studies, covering 381 people in total, using oral or topical saw palmetto at doses of 100 to 320 mg. [1]
The headline results, study by study:
Men using a saw palmetto lotion gained 27% in total hair count at 50 weeks, against about 14% on the vehicle lotion. Hair mass and calibre improved by 30% at 50 weeks against up to 8% on vehicle. [1]
In one placebo-controlled trial, 60% of the saw palmetto group showed improved hair quality and slowed loss, against 11% on placebo. [1]
In the only direct comparison, 320 mg of saw palmetto daily was tested against 1 mg of finasteride daily for 24 months. Finasteride improved hair density in 68% of men. Saw palmetto improved it in 38%, and stabilised progression in 52%. [1]
Across the studies, saw palmetto was well tolerated with no serious adverse events reported. The review's own conclusion matters as much as the numbers: robust, high-quality data are still lacking, and larger trials are needed to confirm the effect. [1]
How does it compare with prescribed treatment?
NHS guidance names finasteride and minoxidil as the main treatments for male pattern baldness, with minoxidil also used for female pattern loss. Neither works for everyone, and both work only for as long as they are used. [2]
The fairest reading of the evidence is this: saw palmetto looks better than doing nothing, and clearly weaker than finasteride in the one trial that tested them head to head. If your goal is the largest proven effect, prescribed treatment has the stronger case. If you cannot or do not want to take finasteride, saw palmetto has a modest evidence base and a clean safety record so far. [1,2]
What about other natural DHT blockers?
Pumpkin seed oil, rosemary oil, caffeine shampoos and biotin are marketed the same way. The pattern is familiar: small studies, short durations, promising early signals and no large confirmatory trials. The saw palmetto review is honest that even its best findings come from a small total pool of 381 people. Treat every bold label claim the same way: ask for the study size, the duration and who measured the result. [1]
What a doctor-led plan looks like
The right first step is not a supplement or a treatment. It is a diagnosis. Pattern loss, telogen effluvium, iron deficiency and thyroid problems can look identical in the mirror, and they need different treatment. NHS guidance is direct: see a GP or specialist to identify the cause before paying a commercial clinic for anything. [2]
At The London PRP Clinic, an assessment maps the pattern, reviews the possible drivers and agrees what success would look like before any treatment starts. Where PRP is appropriate, hair PRP is Β£450 per session or Β£1,215 for three sessions , with the plan and review points set out first. Read the clinic's honest evidence guide and how minoxidil, finasteride and PRP compare . [4,5]
Common questions
Can I take saw palmetto with finasteride or minoxidil?
No trial has tested the combination properly. Tell your doctor everything you are taking so the plan is built on facts, not guesswork. [1]
Is saw palmetto safe for women?
The hair loss studies mostly enrolled men. Because saw palmetto affects hormone pathways, women who are pregnant, trying to conceive or breastfeeding should not take it without medical advice. [1]
How long before I would see a difference?
In the trials, measurable changes appeared from about 10 weeks, with the larger effects at 24 to 50 weeks. Any product promising visible regrowth in days is ahead of its evidence. [1]
Will it help a bald patch that appeared suddenly?
Studies of saw palmetto cover pattern loss and telogen effluvium, not alopecia areata or scarring conditions. Sudden patchy loss needs a diagnosis first. [1,2]
Arrange the right next step
A useful plan starts with the diagnosis, then the treatment and a review point. Request a consultation , call 020 3951 3429 , or email team@thewellnesslondon.com .
Message the team on WhatsApp .
Sources
StatPearls: Androgenetic Alopecia .
The London PRP Clinic: Minoxidil, finasteride or PRP, which first? .
The London PRP Clinic: assessment, treatment options and current prices .
The Wellness Clinical Team. Sources checked 17 October 2026. General information, not an individual diagnosis or treatment plan.